Click to go to DrugInjuryLaw Home


Legal information and news about prescription drug side effects
Avandia Case Evaluation Tequin Case Evaluation Ortho Evra Case EvaluationKetek Case Evaluation Fosamax Case Evaluation\ Permax Case Evaluation Zelnorm Case Evaluation Vytorin Case Evaluation
Dostinex Case Evaluation Bextra Case Evaluation NuvaRing Case Evalulation Natrecor Case Evaluation Crestor Case Evaluation Vioxx Case EvaluationDigitek Case Evaluation

Medical Device Alert: Medtronic Recalls Sprint Fidelis Heart Lead Wire

Free Case Evaluation

Thomas J. Lamb Attorney Profile

Tom Lamb
Education
  • George Washington University, Washington, DC, 1988, J.D.
  • College of William and Mary, Williamsburg, VA, 1983, B.A.
Bar Admissions
  • North Carolina, 1992
  • District of Columbia, 1990
  • California, 1988
Affiliations
  • American Association for Justice
  • North Carolina Advocates for Justice
  • North Carolina Bar Association
  • North Carolina State Bar

You can read news and information about prescription drug side effects at DrugInjuryWatch.com, Tom Lamb's blog which includes drug safety alerts and legal case updates.

 

  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • DrugInjuryLaw.com is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535
email: ThomasJLamb@DrugInjuryLaw.com
Disclaimer